Thoracic radiotherapy for limited-stage small-cell lung cancer: Controversies and future developments

Research output: Contribution to journalArticlepeer-review


Thoracic radiotherapy has an established role in the management of limited-disease small-cell lung cancer (LD SCLC). However, essential questions relating to the optimisation of thoracic radiotherapy remain unanswered, including volume of irradiation, optimal total dose, fractionation, timing and sequencing of radiation. This review highlights the need for well-designed multi-national trials aimed at the optimisation and standardisation of radiotherapy for LD SCLC. © 2005 Published by Elsevier Ltd on behalf of the Royal College of Radiologists.

Bibliographical metadata

Original languageEnglish
Pages (from-to)591-598
Number of pages7
JournalClinical Oncology
Issue number8
Publication statusPublished - Dec 2005